Dibucaine Ointment Formulation and Filling
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture and packaging of Dibucaine Ointment, USP, to support prime contractors fulfilling DLA medical supply contracts. The scope of work requires the formulation of an ointment containing 1% Dibucaine active ingredient, which must be filled into 1 oz / 28g collapsible tubes equipped with rectal applicators. To ensure product quality and safety, the finished units must maintain a 36-month shelf life. Compliance is a critical component of this agreement, requiring the provider to maintain FDA registration and strictly adhere to current Good Manufacturing Practices and USP standards. The opportunity is categorized under NAICS code 325412, with a response deadline set for November 9, 2026.
General Info
Place of Performance
POLSet-Aside
Documents
This scope was carved out of SPE2DP-27-T-0214.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
DIBUCAINE OINTMENT
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
